These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11325969)

  • 1. Insulin induces suppressor of cytokine signaling-3 tyrosine phosphorylation through janus-activated kinase.
    Peraldi P; Filloux C; Emanuelli B; Hilton DJ; Van Obberghen E
    J Biol Chem; 2001 Jul; 276(27):24614-20. PubMed ID: 11325969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
    Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
    Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOCS-3 is an insulin-induced negative regulator of insulin signaling.
    Emanuelli B; Peraldi P; Filloux C; Sawka-Verhelle D; Hilton D; Van Obberghen E
    J Biol Chem; 2000 May; 275(21):15985-91. PubMed ID: 10821852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
    Le MN; Kohanski RA; Wang LH; Sadowski HB
    Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function.
    Flowers LO; Johnson HM; Mujtaba MG; Ellis MR; Haider SM; Subramaniam PS
    J Immunol; 2004 Jun; 172(12):7510-8. PubMed ID: 15187130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C; Susini C; Melmed S
    J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes.
    Fasshauer M; Kralisch S; Klier M; Lossner U; Bluher M; Klein J; Paschke R
    J Endocrinol; 2004 Apr; 181(1):129-38. PubMed ID: 15072573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling.
    Pezet A; Favre H; Kelly PA; Edery M
    J Biol Chem; 1999 Aug; 274(35):24497-502. PubMed ID: 10455112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain.
    Sasaki A; Yasukawa H; Suzuki A; Kamizono S; Syoda T; Kinjyo I; Sasaki M; Johnston JA; Yoshimura A
    Genes Cells; 1999 Jun; 4(6):339-51. PubMed ID: 10421843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice.
    Emanuelli B; Peraldi P; Filloux C; Chavey C; Freidinger K; Hilton DJ; Hotamisligil GS; Van Obberghen E
    J Biol Chem; 2001 Dec; 276(51):47944-9. PubMed ID: 11604392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of critical residues required for suppressor of cytokine signaling-specific regulation of interleukin-4 signaling.
    Haque SJ; Harbor PC; Williams BR
    J Biol Chem; 2000 Aug; 275(34):26500-6. PubMed ID: 10950967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
    Tomic S; Chughtai N; Ali S
    Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
    Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
    Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor activity of SOCS-1.
    Rottapel R; Ilangumaran S; Neale C; La Rose J; Ho JM; Nguyen MH; Barber D; Dubreuil P; de Sepulveda P
    Oncogene; 2002 Jun; 21(28):4351-62. PubMed ID: 12080466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras.
    Cacalano NA; Sanden D; Johnston JA
    Nat Cell Biol; 2001 May; 3(5):460-5. PubMed ID: 11331873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of SOCS3 phosphorylation upon interleukin-6 stimulation. Contributions of Src- and receptor-tyrosine kinases.
    Sommer U; Schmid C; Sobota RM; Lehmann U; Stevenson NJ; Johnston JA; Schaper F; Heinrich PC; Haan S
    J Biol Chem; 2005 Sep; 280(36):31478-88. PubMed ID: 16000307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems.
    Calegari VC; Alves M; Picardi PK; Inoue RY; Franchini KG; Saad MJ; Velloso LA
    Endocrinology; 2005 Feb; 146(2):579-88. PubMed ID: 15514089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor.
    Dey BR; Furlanetto RW; Nissley P
    Biochem Biophys Res Commun; 2000 Nov; 278(1):38-43. PubMed ID: 11071852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase.
    Yamauchi T; Kaburagi Y; Ueki K; Tsuji Y; Stark GR; Kerr IM; Tsushima T; Akanuma Y; Komuro I; Tobe K; Yazaki Y; Kadowaki T
    J Biol Chem; 1998 Jun; 273(25):15719-26. PubMed ID: 9624169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.